Profile data is unavailable for this security.
About the company
ANGELALIGN TECHNOLOGY Inc is a clear aligner dental treatment solution provider. The Company provides dental professionals with self-developed digital orthodontics solutions. The Company’s Angelalign clear aligner system facilitate dental professionals throughout the entire clear aligner treatment process, include digitally-assisted case assessment support and treatment planning services, provide dental professionals with digitally-assisted case assessment support and treatment planning services, help dental professionals design, review and modify treatment plans; customized, removable clear aligners based on specific treatment plans, is a removable, transparent, plastic form of dental braces used to treat malocclusion; and cloud-based service platform, iOrtho, helps to placing orders, reviewing, modifying and finalizing their treatment plans online with the help from its medical designers, and reviewing, editing and managing medical records of their patients.
- Revenue in HKD (TTM)1.60bn
- Net income in HKD57.85m
- Incorporated2018
- Employees2.88k
- LocationAngelalign Technology IncYangpu DistrictSHANGHAI ChinaCHN
- Websitehttps://www.angelalign.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LifeTech Scientific Corp | 1.37bn | 284.76m | 7.41bn | 1.45k | 25.19 | 2.03 | 38.91 | 5.40 | 0.0635 | 0.0635 | 0.3083 | 0.7874 | 0.3022 | 0.7491 | 10.46 | 947,959.90 | 2.56 | 7.09 | 3.05 | 8.51 | 78.57 | 79.66 | 8.48 | 22.69 | 2.27 | -- | 0.1459 | 0.00 | 15.48 | 17.88 | -19.09 | 16.80 | 26.11 | -- |
| Lepu Scientch Mdcl Tchnlgy Shnghi Co Ltd | 352.53m | 163.92m | 7.92bn | 219.00 | 48.34 | 3.80 | 44.56 | 22.48 | 0.4727 | 0.4727 | 1.02 | 6.01 | 0.1717 | 0.5848 | 10.30 | 1,609,743.00 | 7.98 | -- | 8.25 | -- | 88.62 | -- | 46.50 | -- | 22.93 | -- | 0.0013 | -- | 31.58 | -- | 864.81 | -- | -- | -- |
| Kangji Medical Holdings Ltd | 1.00bn | 545.22m | 8.32bn | 1.00k | 14.73 | 2.11 | 15.85 | 8.31 | 0.4649 | 0.4649 | 0.8542 | 3.25 | 0.2245 | 1.76 | 4.76 | 998,717.10 | 10.97 | 14.40 | 12.45 | 16.18 | 80.04 | 81.75 | 48.84 | 57.24 | 17.16 | -- | 0.011 | 49.56 | 17.76 | 21.23 | 5.28 | 28.00 | 41.50 | -- |
| MicroPort Scientific Corp | 7.45bn | -3.74bn | 9.91bn | 8.23k | -- | 1.67 | -- | 1.33 | -2.05 | -2.05 | 4.08 | 3.24 | 0.2399 | 1.09 | 3.95 | 904,759.80 | -16.38 | -11.85 | -27.68 | -18.04 | 55.97 | 62.96 | -68.28 | -44.43 | 1.26 | -5.82 | 0.5477 | -- | 13.07 | 7.27 | -9.42 | -- | -- | -- |
| Shanghai MicroPort MedBot Group Co Ltd | 113.14m | -1.09bn | 11.52bn | 650.00 | -- | 20.50 | -- | 101.84 | -1.14 | -1.14 | 0.118 | 0.5862 | 0.0623 | 0.3746 | 3.75 | 174,063.10 | -60.96 | -- | -86.19 | -- | 14.05 | -- | -978.59 | -- | 0.8238 | -10.84 | 0.5427 | -- | 384.16 | -- | 11.20 | -- | -- | -- |
| Angelalign Technology Inc | 1.60bn | 57.85m | 12.31bn | 2.88k | 212.38 | 3.41 | 85.01 | 7.71 | 0.3428 | 0.3428 | 9.46 | 21.37 | 0.3194 | 5.33 | 11.98 | 553,799.40 | 1.05 | 5.76 | 1.29 | 7.59 | 62.38 | 64.33 | 3.30 | 13.98 | 4.12 | -- | 0.0188 | -- | 16.24 | 24.75 | -74.99 | -2.20 | 20.54 | -- |
| Shanghai Haohai Biological Technology | 2.85bn | 450.13m | 15.00bn | 2.16k | 14.40 | 1.04 | 22.73 | 5.26 | 2.64 | 2.64 | 16.71 | 36.58 | 0.3765 | 1.55 | 7.50 | 1,320,797.00 | 5.89 | 4.84 | 6.86 | 5.50 | 70.34 | 72.09 | 15.65 | 16.50 | 4.50 | -- | 0.0635 | 36.86 | 25.27 | 11.26 | 130.58 | 0.0762 | 11.96 | 14.27 |
| Holder | Shares | % Held |
|---|---|---|
| Aegon-Industrial Fund Management Co., Ltd.as of 14 Jun 2023 | 8.47m | 5.01% |
| Capital Research & Management Co. (World Investors)as of 31 Mar 2024 | 5.69m | 3.36% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 1.70m | 1.01% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 1.52m | 0.90% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2023 | 822.60k | 0.49% |
| Grandeur Peak Global Advisors LLCas of 31 Jan 2024 | 735.00k | 0.44% |
| Nordea Investment Management AB (Denmark)as of 31 Dec 2023 | 715.11k | 0.42% |
| China Asset Management Co., Ltd.as of 30 Jun 2023 | 580.80k | 0.34% |
| Fidelity Management & Research Co. LLCas of 29 Feb 2024 | 578.62k | 0.34% |
| Capital Research & Management Co. (Global Investors)as of 31 Mar 2024 | 547.35k | 0.32% |
